Systematic review of 88 studies (23,737 patients) on BTK inhibitors: in 16 studies using EORTC/MSGERC definitions, pooled prevalence of proven/probable invasive fungal infection was 2.83%; concurrent corticosteroids (OR 5.03) and 3 or more prior therapy lines were risk factors.
Meta-analysisn = 23,737
Srisurapanont et al. Invasive fungal infections after Bruton tyrosine kinase inhibitor treatment: a systematic review and meta-analysis